Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAAA NIH HHS
Grant: R01 AA025368
NIAAA NIH HHS
Grant: R21 AA026949
NIDA NIH HHS
Grant: R21 DA034106
NIDA NIH HHS
Grant: R03 DA045897
NIDA NIH HHS
Grant: R33 DA045884
National Institutes of Health
Grant: 1R03DA045897-01
Development of G-protein biased delta opioid receptor agonist with analgesic potency
National Institutes of Health
Grant: 1R21AA026675-01
The influence of alcohol on the metastatic dormancy of breast cancer
National Institutes of Health
Grant: 5R21AA026949-02
Opioidergic alkaloids from Mitragynia Speciosa (kratom) as novel treatment for alcohol use disorder
National Institutes of Health
Grant: 1R01AA025368-01A1
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
National Institutes of Health
Grant: 4R33DA045884-03
Pharmacological Probes based on mitragynine pseudoindoxyl
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
FWCI
4.38
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals